Rohan Fernandes

Rohan Fernandes

George Washington University

H-index: 29

North America-United States

About Rohan Fernandes

Rohan Fernandes, With an exceptional h-index of 29 and a recent h-index of 23 (since 2020), a distinguished researcher at George Washington University, specializes in the field of Nanomedicine, Immunoengineering, Cell Therapy, Cancer, HIV.

His recent articles reflect a diverse array of research interests and contributions to the field:

503 Engineering GBM-specific T Cells Using Photothermal Prussian Blue Nanoparticles

Generation of multi-antigen specific T cells for ovarian cancer using Prussian Blue nanoparticles and photothermal therapy

Tunneling CARs: Gene modifications to enhance CAR-T infiltration into solid tumors

Reprogramming tumor microenvironment with intratumor macrophage adoptive cell therapy in melanoma

Functionalized Prussian blue nanoparticles, combination Prussian blue nanoparticle-based nano-immunotherapy and applications thereof

Nanoparticle-mediated immune cell manufacture and use thereof

Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIV

Photothermal Prussian blue nanoparticles generate potent multi‐targeted tumor‐specific T cells as an adoptive cell therapy

Rohan Fernandes Information

University

Position

Associate Professor

Citations(all)

3007

Citations(since 2020)

1654

Cited By

2016

hIndex(all)

29

hIndex(since 2020)

23

i10Index(all)

41

i10Index(since 2020)

33

Email

University Profile Page

Google Scholar

Rohan Fernandes Skills & Research Interests

Nanomedicine

Immunoengineering

Cell Therapy

Cancer

HIV

Top articles of Rohan Fernandes

503 Engineering GBM-specific T Cells Using Photothermal Prussian Blue Nanoparticles

Neurosurgery

2024/4/1

Generation of multi-antigen specific T cells for ovarian cancer using Prussian Blue nanoparticles and photothermal therapy

Cancer Research

2024/3/22

Tunneling CARs: Gene modifications to enhance CAR-T infiltration into solid tumors

Cancer Research

2024/3/22

Reprogramming tumor microenvironment with intratumor macrophage adoptive cell therapy in melanoma

Cancer Research

2024/3/22

Functionalized Prussian blue nanoparticles, combination Prussian blue nanoparticle-based nano-immunotherapy and applications thereof

2024/3/19

Nanoparticle-mediated immune cell manufacture and use thereof

2024/1/25

Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIV

International journal of nanomedicine

2023/12/31

Photothermal Prussian blue nanoparticles generate potent multi‐targeted tumor‐specific T cells as an adoptive cell therapy

Bioengineering & Translational Medicine

2023/12/22

Engineered tumor-specific T cells using immunostimulatory photothermal nanoparticles

Cytotherapy

2023/7/1

Prussian blue nanoparticles functionalization with latency reversing agents and broadly neutralizing antibodies, and applications thereof

2023/6/22

Prussian blue nanoparticles functionalized with immune signals and applications thereof

2023/6/13

Reprogramming macrophages with HDAC6 inhibitors for anti-cancer macrophage-based cell therapy

Survival

2023/4/4

PolyIC-coated Prussian blue nanoparticles as a dual-mode HIV latency reversing agent

Nanomedicine

2022/12

Rohan Fernandes
Rohan Fernandes

H-Index: 20

Compositions and methods for treatment of immune checkpoint resistant cancers

2022/10/13

Interstitial photothermal therapy generates durable treatment responses in neuroblastoma

Advanced healthcare materials

2022/10

Anti-Fn14-conjugated Prussian blue nanoparticles as a targeted photothermal therapy agent for glioblastoma

Nanomaterials

2022/8/1

Rohan Fernandes
Rohan Fernandes

H-Index: 20

Gene Editing/Gene Therapies: HUMAN ALLOGENEIC NK CELLS MODIFIED TO EXPRESS A TGF-β DOMINANT NEGATIVE RECEPTOR AND IL-15 DISPLAY A STRONG ANTI-TUMOR ACTIVITY IN AN NSG MOUSE …

Cytotherapy

2022/5/1

The thermal dose of photothermal therapy generates differential immunogenicity in human neuroblastoma cells

Cancers

2022/3/11

Palak Sekhri
Palak Sekhri

H-Index: 5

Rohan Fernandes
Rohan Fernandes

H-Index: 20

CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanoma

Nano research

2022/3/1

An Engineered Prussian Blue Nanoparticles‐Based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH‐MYCN Neuroblastoma Model

Advanced nanobiomed research

2021/8

Juliana Cano-Mejia
Juliana Cano-Mejia

H-Index: 5

Rohan Fernandes
Rohan Fernandes

H-Index: 20

See List of Professors in Rohan Fernandes University(George Washington University)